Literature DB >> 15565809

TRAIL induction by radiation in lymphoma patients.

Jaya Unnithan1, Roger M Macklis.   

Abstract

TRAIL/Apo-2 L, a member of the Tumor Necrosis Factor cytokine family, induces apoptosis specifically in malignant cells. A combination of TRAIL and radiation is highly synergistic in in vitro experiments. In addition to this additive effect, we observed that TRAIL is induced by irradiation of certain cell lines. The induction begins approximately 2 hours after irradiation. This might even enhance the antineoplastic effect of ionizing radiation and partially explain the abscopal effect observed in hematopoietic malignancies. TRAIL levels were evaluated in 17 patients treated with radiation for Hodgkin's and non-Hodgkin's lymphoma. We did not observe a specific TRAIL expression pattern that could be correlated with histology, disease status, volume of disease, radiation dose, and other antineoplastic therapies, but a definite pattern observed in a single patient remained constant over time. TRAIL and interferons display a common pattern of gene expression at certain nodal points of interaction between the two physiologic pathways. Our hypothesis is that the radiation-induced changes in TRAIL expression observed in patients undergoing therapeutic radiation may be emblematic of the various physiologic pathways induced or inhibited by ionizing radiation and may even be partially responsible for the "bystander effect" observed in unirradiated cells in close proximity to irradiated cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15565809     DOI: 10.1081/cnv-200026397

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  5 in total

Review 1.  Exploiting sensitization windows of opportunity in hyper and hypo-fractionated radiation therapy.

Authors:  Anish Prasanna; Mansoor M Ahmed; Mohammed Mohiuddin; C Norman Coleman
Journal:  J Thorac Dis       Date:  2014-04       Impact factor: 2.895

2.  TNF related apoptosis-inducing ligand and its receptors in ocular tumors.

Authors:  Qian Ning; Lei Hou; Min Meng; Bo-Rong Pan; Xin-Han Zhao
Journal:  Int J Ophthalmol       Date:  2011-10-18       Impact factor: 1.779

Review 3.  Regulation of the human TRAIL gene.

Authors:  Joshua E Allen; Wafik S El-Deiry
Journal:  Cancer Biol Ther       Date:  2012-08-15       Impact factor: 4.742

Review 4.  TNF-related apoptosis inducing ligand in ocular cancers and ocular diabetic complications.

Authors:  Paolo Perri; Giorgio Zauli; Arianna Gonelli; Daniela Milani; Claudio Celeghini; Giuseppe Lamberti; Paola Secchiero
Journal:  Biomed Res Int       Date:  2015-03-05       Impact factor: 3.411

5.  Inhibition of COX-2 expression by topical diclofenac enhanced radiation sensitivity via enhancement of TRAIL in human prostate adenocarcinoma xenograft model.

Authors:  Takeshi Inoue; Satoshi Anai; Sayuri Onishi; Makito Miyake; Nobumichi Tanaka; Akihide Hirayama; Kiyohide Fujimoto; Yoshihiko Hirao
Journal:  BMC Urol       Date:  2013-01-05       Impact factor: 2.264

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.